Association between the Prognostic Nutritional Index and the Occurrence of Immune-Related Adverse Events

In conclusion, pretreatment PNI may be associated with the risk of developing irAEs in patients with advanced recurrent solid tumors. When the PNI is ≥44.2, patient management is important for avoiding serious AEs because while the treatment may be effective, the occurrence of irAEs is a concern.PMID:38311396 | DOI:10.1248/bpb.b23-00760

Source: Biological and Pharmaceutical Bulletin - February 4, 2024 Category: Drugs & Pharmacology Authors: Tatsuya Furuno Rintaro Sogawa Takanori Hashimoto Shunsuke Matsuo Wakako Shirahama Tomoko Kamura Kazuhisa Hosoya Yoko Senjyu Yoshio Yamashita Takuya Inoue Moriyasu Yamauchi Hiroo Katsuya Mitsuru Noguchi Naoko Sueoka-Aragane Chisato Shimanoe Source Type: research